Sernova Corp T.SVA

Q&A?

[Ekenbullets]

Did they manage any Q&A this time?

[MustangSalley]

Actually Q&A was done very well.   Overall take always : Pouch is superior to competitors because it is retrievable unlike Semma. Peritoneal cavity has limitations . There is no vasualrization in pertioneal cavity . Dumping cells via portal vein has limitations not  viable longterm . conformal coding is proven to work in animal models including primates . Conformal coating

[Redbaron2211]

Was good, definitely geared towards the science and stayed mostly technical but some good tidbits in there for investors.   Immunosuppression is a very important step and conformal coating going well preclinical brings all the pieces of the puzzle into the light.  It might not be a short term catalyst but it sure supports the thesis that Sernova has what it takes for a functional

[Charly50]

Dear Salley,   you said it.   I think the bottom line from yesterday's event is the fact that Sernova is way ahead of the competition,( like Semma) and the novel conformal coating technology for cellular immune protection is being advanced.    Sernova is on a very good path!!! Redbaron described it very nicely and I take the liberty to add that the event was very

[0checker]

https://scitechdaily.com/building-a-better-bioartificial-pancreas-for-more-effective-treatment-for-people-with-type-1-diabetes/